BioNTech SE - ADR

NASDAQ:BNTX   4:00:00 PM EDT
98.30
+1.44 (+1.49%)
: $98.50 +0.20 (+0.20%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)23.37B
Current PE8.49
Forward PE 21.56
2yr Forward PE 35.88
See more stats
Estimates Current Quarter
Revenue$2.27 Billion
Adjusted EPS$2.88
See more estimates
10-Day MA$98.30
50-Day MA$100.66
200-Day MA$112.32
See more pivots

BioNTech SE - ADR Stock, NASDAQ:BNTX

An der Goldgrube 12, Mainz, Rheinland-Pfalz 55131
Germany
Phone: +49.6131.9084.0
Number of Employees: 4530
http://www.biontech.de

Description

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.